XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Collaborative Arrangements - Bayer AG (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 15,775 $ 14,487  
Cost of sales 3,540 3,926  
Selling, general and administrative 2,483 2,479  
Research and development 3,992 4,276  
Other current assets 31,445   $ 32,168
Accrued and other current liabilities 14,102   15,766
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Eligible future contingent sales-based milestone payments (up to) 0    
Revenue from collaborative arrangement 98 99  
Sales 173 165  
Cost of sales 62 57  
Selling, general and administrative 33 33  
Research and development 28 25  
Other current assets 155   156
Accrued and other current liabilities 74   $ 80
Adempas | Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales 70 59  
Adempas | Other Intangible Assets | Licenses and Other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Finite-lived intangible assets 483    
Verquvo | Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales 5 $ 7  
Verquvo | Other Intangible Assets | Licenses and Other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Finite-lived intangible assets $ 49